Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)

NCT00594152 is registered in ClinicalTrials.gov with Joslin Diabetes Center as lead sponsor.

NCT NCT00594152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00594152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
Lead sponsor
Joslin Diabetes Center
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1993
Completion date
January 31, 1995
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy, diabetic retinopathy